Literature DB >> 12809108

A Scandinavian adaptation of the Multi-Clinic Smell and Taste Questionnaire: evaluation of questions about olfaction.

S Nordin1, A Brämerson, C Murphy, M Bende.   

Abstract

OBJECTIVE: A Scandinavian adaptation of the Multi-Clinic Smell and Taste Questionnaire (MCSTQ-Sc) was evaluated with respect to comprehension and test-retest reliability for responses to questions about olfactory dysfunction (abnormal sensitivity, parosmia and phantosmia) and related questions about medical history and consequences of olfactory dysfunction.
MATERIAL AND METHODS: Comprehension was evaluated in a first study in 20 patients with chief complaints of olfactory dysfunction by comparing questionnaire- and interview-based responses. Test-retest reliability was evaluated in a second study in 30 other patients with olfactory complaints.
RESULTS: Data from the two studies suggest that the vast majority of the questions evaluated from the MCSTQ-Sc are comprehensible and generate responses with very good reliability. Distinct exceptions were poor agreement between the questionnaire- and interview-based responses for questions about the number of cigarettes smoked and the pleasantness and typical episode length of phantosmia; the test-retest reliability regarding the nostril side of phantosmia also showed poor agreement. The results suggest the importance of probing these areas further in the clinical interview.
CONCLUSION: The findings imply that, with a few caveats, the MCSTQ-Sc is a useful tool for the clinical assessment of olfactory dysfunction and its consequences.

Entities:  

Mesh:

Year:  2003        PMID: 12809108     DOI: 10.1080/00016480310001411

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  9 in total

1.  Assessing taste and smell alterations in cancer patients undergoing chemotherapy according to treatment.

Authors:  Javier Amézaga; Begoña Alfaro; Yolanda Ríos; Aitziber Larraioz; Gurutze Ugartemendia; Ander Urruticoechea; Itziar Tueros
Journal:  Support Care Cancer       Date:  2018-05-31       Impact factor: 3.603

2.  Application of the European Test of Olfactory Capabilities in patients with olfactory impairment.

Authors:  P Joussain; M Bessy; F Faure; D Bellil; B N Landis; M Hugentobler; H Tuorila; S Mustonen; S I Vento; F Delphin-Combe; P Krolak-Salmon; C Rouby; M Bensafi
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-25       Impact factor: 2.503

3.  Self-reported taste and smell changes during cancer chemotherapy.

Authors:  Britt-Marie Bernhardson; Carol Tishelman; Lars E Rutqvist
Journal:  Support Care Cancer       Date:  2007-08-21       Impact factor: 3.603

4.  A short Chemical Sensitivity Scale for assessment of airway sensory hyperreactivity.

Authors:  Steven Nordin; Eva Millqvist; Olle Löwhagen; Mats Bende
Journal:  Int Arch Occup Environ Health       Date:  2004-03-16       Impact factor: 3.015

5.  Crossmodal effect of music and odor pleasantness on olfactory quality perception.

Authors:  Carlos Velasco; Diana Balboa; Fernando Marmolejo-Ramos; Charles Spence
Journal:  Front Psychol       Date:  2014-11-28

Review 6.  Depression, Olfaction, and Quality of Life: A Mutual Relationship.

Authors:  Marion Rochet; Wissam El-Hage; Sami Richa; François Kazour; Boriana Atanasova
Journal:  Brain Sci       Date:  2018-05-04

7.  Impact of the smell loss on the quality of life and adopted coping strategies in COVID-19 patients.

Authors:  Safaa Mostafa Ali Elkholi; Mohamed Kamal Abdelwahab; Marwa Abdelhafeez
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-19       Impact factor: 2.503

8.  Development of a questionnaire to investigate socio-cultural differences in the perception of smell, taste and flavour.

Authors:  Eleonora M C Trecca; Francesca Fortunato; Matteo Gelardi; Paolo Petrone; Michele Cassano
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-08       Impact factor: 2.124

9.  Inflammatory Mediator Profiling of n-butanol Exposed Upper Airways in Individuals with Multiple Chemical Sensitivity.

Authors:  Thomas Meinertz Dantoft; Sine Skovbjerg; Linus Andersson; Anna-Sara Claeson; Nina Lind; Steven Nordin; Susanne Brix
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.